Flu season in northern China occurs during the same period as in the world’s other northern temperate zones, but in the south the disease peaks in the spring, while patterns in a third, intermediate zone are complex and require more research, according to the study, led by researchers from the Fogarty International Center, part of the National Institutes of Health.
Fogarty scientists have been assisting the Chinese Centers for Disease Control and Prevention with flu studies for several years, including providing training to a number of Chinese scientists who have visited the NIH campus.
“This research suggests the need for staggered timing of vaccination in three broad epidemiological regions,” said Dr. Cecile Viboud, who co-authored the study with Fogarty colleagues and Chinese collaborators.
Research conducted by Fogarty and China CDC scientists identifies three regions for influenza vaccination in China: Annual vaccination campaigns should be initiated in October-November in Northern China (purple) and in February-March in Southern China (green) to accommodate local seasonal influenza activity. In the mid-latitude region around Shanghai (yellow), the optimal timing of vaccination is complicated by semi-annual influenza activity and should be clarified based on further research.
The study recommends that northern China conduct annual vaccination campaigns starting in October, as typically recommended for the Northern Hemisphere. Southernmost Chinese provinces, in contrast, would be better off vaccinating beginning in February.
The research published today by PLOS Medicine was part of the Multinational Influenza Seasonal Mortality Study, an ongoing, Fogarty-led collaborative effort to study the epidemiology and evolution of influenza in the tropics and other parts of the globe. The work was funded by the NIH and the Chinese CDC.
The study aimed to characterize the seasonality of the disease across China to help optimize the timing of future vaccination programs. While China introduced seasonal influenza vaccination in 1998, only about 2 percent of the population is routinely immunized. Although health workers in Beijing and a few other cities now vaccinate older adults and school-age children against flu, the country has yet to initiate a country-wide plan. It is estimated that influenza annually causes 11-18 deaths per 100,000 people in China, with underdeveloped rural areas suffering two to three times higher flu-related death rates than wealthier cities.
More research would be helpful to confirm the optimal vaccination policy, particularly for the mid-latitude provinces around Shanghai, the authors stated.
“Before a national influenza vaccination program can be established in this large, climatologically diverse country, public health experts need a clear picture of influenza seasonally across the country that could be used to optimize the timing of a future Chinese vaccination effort,” Viboud said.
Previous studies have shown that while cold temperatures and low humidity favor influenza transmission in temperate settings, flu seasons in tropical climates coincide with periods of high rainfall. Intermediate regions sometimes have twice-annual epidemic cycles, rather than the single season observed, for example, in the United States and Europe.
In the current study, influenza peaked on average between late December and early January in northern China. A weaker but still significant annual peak occurred from mid-May to mid-June in the south. In mid-latitude provinces, there were semi-annual peaks in January-February and again in June-August.
Study data were gathered by collecting samples from participating hospitals in cities in each of China’s 30 provinces from 2005-2011. Statistical analyses enabled the researchers to designate three epidemiologically distinct flu regions.
The immunity stimulated by current flu vaccines tends to decay within four to eight months, so it is vital for people to be vaccinated in the months immediately preceding flu season, the authors noted.
“The situation of mid-latitude Chinese provinces is more complex, due to semi-annual patterns of influenza activity, and longer epidemic periods,” said the authors. “Denser sampling over a longer period of time will have to be done to establish the optimal timing of vaccination in those areas.”
The study’s results were reminiscent of those of a Fogarty-led study set in Brazil, where epidemics originate in the northern equatorial states and move toward the subtropical south over a three-month period, indicating the need for staggered timing of vaccination across the country. Brazil and China have markedly different flu patterns from the United States, for example, where winter epidemics are driven by large population centers and are usually synchronized nationally.
Given the growing interest in rolling out national influenza immunization programs in low- and middle-income countries, the authors suggest these findings highlight the importance of ensuring that vaccination strategies are optimized by taking into account local disease patterns.
Fogarty, the international component of the NIH, addresses global health challenges through innovative and collaborative research and training programs and supports and advances the NIH mission through international partnerships. For more information, visit: http://www.fic.nih.gov.
About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.
NIH…Turning Discovery Into Health®